Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Immunopharmacology
|
May 1, 1996
Heparin-coated devices and high-dose aprotinin optimally inhibit contact system activation in an in vitro cardiopulmonary bypass model
H P Wendel, W Heller, M J Gallimore
British Medical Journal
|
June 2, 1979
Antiplasmin concentrations after surgery
M J Gallimore, A O Aasen, E Amundsen
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor
D W Jones, M J Gallimore, M Winter
Thrombosis and Haemostasis
|
February 12, 1998
Factor XII determinations in the presence and absence of phospholipid antibodies
M J Gallimore, D W Jones, M Winter
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Factor XII determinations and lupus anticoagulants
D W Jones, M J Gallimore, M Winter
Immunopharmacology
|
May 1, 1996
Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass model
H P Wendel, W Heller, M J Gallimore
Immunopharmacology
|
December 30, 1999
FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery
H P Wendel, D W Jones, M J Gallimore
Thrombosis Research
|
May 7, 1999
A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients
M J Gallimore, D W Jones, H P Wendel
Advances in Experimental Medicine and Biology
|
January 1, 1989
Factor XII levels in patients after abdominal surgery
G Fuhrer, M J Gallimore, M Lambrecht, et al.
Journal of Clinical Pathology
|
March 1, 1972
The origin of fibrin breakdown products and the interpretation of their appearance in the circulation
M J Gallimore, H M Tyler, J T Shaw
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Immunopharmacology
|
May 1, 1996
Heparin-coated devices and high-dose aprotinin optimally inhibit contact system activation in an in vitro cardiopulmonary bypass model
H P Wendel, W Heller, M J Gallimore
British Medical Journal
|
June 2, 1979
Antiplasmin concentrations after surgery
M J Gallimore, A O Aasen, E Amundsen
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor
D W Jones, M J Gallimore, M Winter
Thrombosis and Haemostasis
|
February 12, 1998
Factor XII determinations in the presence and absence of phospholipid antibodies
M J Gallimore, D W Jones, M Winter
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Factor XII determinations and lupus anticoagulants
D W Jones, M J Gallimore, M Winter
Immunopharmacology
|
May 1, 1996
Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass model
H P Wendel, W Heller, M J Gallimore
Immunopharmacology
|
December 30, 1999
FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery
H P Wendel, D W Jones, M J Gallimore
Thrombosis Research
|
May 7, 1999
A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients
M J Gallimore, D W Jones, H P Wendel
Advances in Experimental Medicine and Biology
|
January 1, 1989
Factor XII levels in patients after abdominal surgery
G Fuhrer, M J Gallimore, M Lambrecht, et al.
Journal of Clinical Pathology
|
March 1, 1972
The origin of fibrin breakdown products and the interpretation of their appearance in the circulation
M J Gallimore, H M Tyler, J T Shaw
Page
of 7